Lexington, KY, United States of America

Tadeusz Cynkowski

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Kentucky Research Foundation. Active years: 1997-2007.

USPTO Granted Patents = 4 

% Patents Active = 75.0



Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 425(Granted Patents)


Company Filing History:


Years Active: 1997-2007

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tadeusz Cynkowski: Innovator in Chemotherapeutic Prodrugs

Introduction

Tadeusz Cynkowski is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of chemotherapeutic agents, particularly through his innovative work on prodrugs. With a total of 4 patents, Cynkowski's inventions are paving the way for advancements in medical treatments.

Latest Patents

Cynkowski's latest patents include "Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids." This invention relates to the development of prodrugs that enhance the delivery and efficacy of chemotherapeutic agents. The focus on permeability and solubility addresses critical challenges in drug formulation, making treatments more effective and less irritating for patients.

Career Highlights

Throughout his career, Tadeusz Cynkowski has worked with esteemed organizations such as the University of Kentucky Research Foundation. His research has contributed to the understanding and application of prodrugs in cancer therapy, showcasing his commitment to improving patient outcomes.

Collaborations

Cynkowski has collaborated with notable individuals in his field, including Paul Ashton and Peter Anthony Crooks. These partnerships have fostered a collaborative environment that enhances innovation and research in chemotherapeutic applications.

Conclusion

Tadeusz Cynkowski's work in the development of prodrugs represents a significant advancement in the field of chemotherapeutics. His innovative approach and dedication to research continue to impact the medical community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…